Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
J Immunol ; 184(1): 45-55, 2010 Jan 01.
Article in English | MEDLINE | ID: mdl-19949110

ABSTRACT

Previous studies of CD8(+) T cell immunodominance after primary virus infection of F(1) mice compared with their inbred parents have generally concluded that no dramatic changes occur. In this study, we revisit this issue using vaccinia virus (VACV), which has a large genome, a recently defined immunodominance hierarchy in mice, and is a candidate vector for vaccines. We found that immunogenicity of VACV peptides defined using inbred mice was highly variable in F(1) progeny: some peptides were equally immunogenic in F(1) and inbred, whereas others elicited responses that were reduced by >90% in F(1) mice. Furthermore, the dominance of a peptide in the relevant inbred parent did not predict whether it would be poorly immunogenic in F(1) mice. This result held using F(1) hybrids of MHC-congenic mice, suggesting that MHC differences alone were responsible. It was also extended to foreign epitopes expressed by an rVACV vaccine. F(1) mice were less able to mount responses to the poorly immunogenic peptides when used as a sole immunogen, ruling out immunodomination. In addition, conserved TCR Vbeta usage between inbred and F(1) mice did not always correlate with strong responses in F(1) mice. However, direct estimation of naive precursor numbers showed that these were reduced in F(1) compared with inbred mice for specificities that were poorly immunogenic in the hybrids. These data have implications for our understanding of the extent to which MHC diversity alters the range of epitopes that are immunogenic in outbred populations.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Immunodominant Epitopes/genetics , Major Histocompatibility Complex/genetics , Vaccinia virus/immunology , Vaccinia/immunology , Animals , Antigens, Viral/immunology , Epitopes, T-Lymphocyte/genetics , Epitopes, T-Lymphocyte/immunology , Immunodominant Epitopes/immunology , Immunogenetic Phenomena , Major Histocompatibility Complex/immunology , Mice , Vaccinia/genetics , Vaccinia virus/genetics
2.
Immunol Cell Biol ; 88(4): 461-7, 2010.
Article in English | MEDLINE | ID: mdl-20066003

ABSTRACT

Smallpox was a deadly disease when it was rife yet despite its eradication more than 30 years ago, the possibility of accidental or intentional release has driven research in search of better definitions of correlates of protective immunity. Mousepox, a disease caused by ectromelia virus (ECTV), is arguably one of the best surrogate small animal models for smallpox. Correlates of protection in mousepox are well defined during primary infection, whereas those in a secondary infection, which have definite relevance to vaccination strategies, are less well understood. We previously established that neutralizing antibody (Ab), which is generated far more rapidly during a secondary infection compared with a primary infection, has a key role during a secondary virus challenge. In this study, we show that the route of immunization or the use of homologous or heterologous virus vaccines for immunization does not influence the ability of mice to control high-dose virulent ECTV challenge or to mount a substantial secondary neutralizing Ab response. In contrast, the recall cytotoxic T lymphocyte (CTL) responses generated under these regimes of immunization were varied and did not correlate with virus control. Furthermore, unlike the recall Ab response that was generated rapidly, the kinetics of the secondary antiviral CTL response was no different to a primary infection and peaked only at day 8 post-challenge. This finding further underscores the importance of Ab in conferring protection during secondary poxvirus infection. This information could potentially prove useful in the design of safer and more efficacious vaccines against poxviruses or other diseases using poxvirus vectors.


Subject(s)
Ectromelia virus , Immunity, Cellular , Immunity, Humoral , Immunization , Immunologic Memory , Animals , Antibody Formation , Antiviral Agents/pharmacology , Ectromelia virus/drug effects , Female , Flow Cytometry , Mice , Mice, Inbred C57BL , T-Lymphocytes, Cytotoxic/cytology , T-Lymphocytes, Cytotoxic/immunology
3.
Novartis Found Symp ; 281: 129-36; discussion 136-40, 208-9, 2007.
Article in English | MEDLINE | ID: mdl-17534070

ABSTRACT

There is increased interest in understanding protective immunity to smallpox for two principal reasons. First, it is the only disease that has been successfully eradicated using a live virus vaccine and, second, there exists a potential threat of intentional or unintentional release of variola virus, the causative agent of smallpox. Although mortality rates associated with smallpox were as high as 40%, a significant subset of those infected recovered. The basis of susceptibility or resistance, and the immune parameters associated with recovery, are still unknown. Animal models of poxvirus infections are being employed to understand what constitutes an effective host response. Ectromelia virus is closely related to variola virus and it causes a disease similar to smallpox in mice. This model is well established, resistant and susceptible strains of mice are defined and four genetic loci associated with resistance have been identified. Susceptibility to infec tion and disease severity is also influenced by virus immune evasion strategies. The outcome of infection is clearly dictated by several factors including host and viral genes, both of which influence the immune response. Here we present data on one virus-encoded immune modifier and its effect on the functions of two host genetic loci associ ated with resistance.


Subject(s)
Disease Models, Animal , Ectromelia virus/immunology , Ectromelia, Infectious/immunology , Genetic Predisposition to Disease/genetics , Smallpox/immunology , Animals , Ectromelia, Infectious/genetics , Humans , Mice , Mice, Inbred C57BL , Smallpox/genetics
4.
Cell Host Microbe ; 8(2): 174-85, 2010 Aug 19.
Article in English | MEDLINE | ID: mdl-20709294

ABSTRACT

Vaccinia immunization was pivotal to successful smallpox eradication. However, the early immune responses that distinguish poxvirus immunization from pathogenic infection remain unknown. To address this, we developed a strategy to map the activation of key signaling networks in vivo and applied this approach to define and compare the earliest signaling events elicited by immunizing (vaccinia) and lethal (ectromelia) poxvirus infections in mice. Vaccinia induced rapid TLR2-dependent responses, leading to IL-6 production, which then initiated STAT3 signaling in dendritic and T cells. In contrast, ectromelia did not induce TLR2 activation, and profound mouse strain-dependent responses were observed. In resistant C57BL/6 mice, the STAT1 and STAT3 pathways were rapidly activated, whereas in susceptible BALB/c mice, IL-6-dependent STAT3 activation did not occur. These data link early immune signaling events to infection outcome and suggest that activation of different pattern-recognition receptors early after infection may be important in determining vaccine efficacy.


Subject(s)
Ectromelia virus/immunology , Ectromelia, Infectious/immunology , Vaccinia virus/immunology , Vaccinia/immunology , Animals , Cell Line , Dendritic Cells/immunology , Genetic Predisposition to Disease , Host Specificity/immunology , Humans , Immunization , Interleukin-6/physiology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , STAT1 Transcription Factor/metabolism , STAT3 Transcription Factor/metabolism , Signal Transduction , T-Lymphocytes/immunology , Toll-Like Receptor 2/physiology
5.
Immunol Cell Biol ; 86(1): 80-6, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17923850

ABSTRACT

Even though smallpox has been eradicated, the threat of accidental or intentional release has highlighted the fact there is little consensus about correlates of protective immunity or immunity against re-infection with the causative poxvirus, variola virus (VARV). As the existing vaccine for smallpox has unacceptable rates of side effects and complications, new vaccines are urgently needed. Surrogate animal models of VARV infection in humans, including vaccinia virus (VACV) and ectromelia virus (ECTV) infection in mice, monkeypox virus (MPXV) infection in macaques have been used as tools to dissect the immune response to poxviruses. Mousepox, caused by ECTV, a natural mouse pathogen, is arguably the best surrogate small-animal model, as it shares many aspects of virus biology, pathology and clinical features with smallpox in humans. The requirements for recovery from a primary ECTV infection have been well characterized and include type I and II interferons, natural killer cells, CD4T cells, CD8T cell effector function and antibody. From a vaccine standpoint, it is imperative that the requirements for recovery from secondary infection are also identified. We have investigated host immune parameters in response to a secondary ECTV infection, and have identified that interferon and CD8T cell effector functions are not essential; however, T- and B-cell interaction and antibody are absolutely critical for recovery from a secondary challenge. The central role of antibody has been also been identified in the secondary response to other poxviruses. These findings have important clinical implications and would greatly assist the design of therapeutic interventions and new vaccines for smallpox.


Subject(s)
Antibodies, Viral/immunology , CD4-Positive T-Lymphocytes/immunology , Immunity, Cellular , Poxviridae Infections/immunology , Poxviridae/immunology , Adolescent , Animals , Antibodies, Viral/metabolism , CD4-Positive T-Lymphocytes/virology , Child , Genetic Predisposition to Disease , Humans , Lymphocyte Cooperation/immunology , Mice , Poxviridae Infections/genetics , Poxviridae Infections/metabolism , Poxviridae Infections/prevention & control , Rabbits , Rats , Smallpox Vaccine/immunology , Smallpox Vaccine/metabolism , Smallpox Vaccine/therapeutic use
6.
J Immunol ; 180(11): 7193-202, 2008 Jun 01.
Article in English | MEDLINE | ID: mdl-18490718

ABSTRACT

Understanding immunity to vaccinia virus (VACV) is important for the development of safer vaccines for smallpox- and poxvirus-vectored recombinant vaccines. VACV is also emerging as an outstanding model for studying CD8(+) T cell immunodominance because of the large number of CD8(+) T cell epitopes known for this virus in both mice and humans. In this study, we characterize the CD8(+) T cell response in vaccinated BALB/c mice by a genome-wide mapping approach. Responses to each of 54 newly identified H-2(d)-restricted T cell epitopes could be detected after i.p. and dermal vaccination routes. Analysis of these new epitopes in the context of those already known for VACV in mice and humans revealed two important findings. First, CD8(+) T cell epitopes are not randomly distributed across the VACV proteome, with some proteins being poorly or nonimmunogenic, while others are immunoprevalent, being frequently recognized across diverse MHC haplotypes. Second, some proteins constituted the major targets of the immune response by a specific haplotype as they recruited the majority of the specific CD8(+) T cells but these proteins did not correspond to the immunoprevalent Ags. Thus, we found a dissociation between immunoprevalence and immunodominance, implying that different sets of rules govern these two phenomena. Together, these findings have clear implications for the design of CD8(+) T cell subunit vaccines and in particular raise the exciting prospect of being able to choose subunits without reference to MHC restriction.


Subject(s)
Antigens, Viral/immunology , CD8-Positive T-Lymphocytes/immunology , Epitopes, T-Lymphocyte/immunology , Vaccinia virus/immunology , Animals , CD8-Positive T-Lymphocytes/metabolism , Cell Line, Tumor , Epitopes, T-Lymphocyte/metabolism , H-2 Antigens/immunology , Immunodominant Epitopes/immunology , Mice , Mice, Inbred BALB C , Proteome/genetics , Proteome/immunology , Vaccination , Viral Vaccines/administration & dosage , Viral Vaccines/immunology
7.
J Virol ; 80(13): 6333-8, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16775321

ABSTRACT

Renewed interest in smallpox and the need for safer vaccines have highlighted our lack of understanding of the requirements for protective immunity. Since smallpox has been eradicated, surrogate animal models of closely related orthopoxviruses, such as ectromelia virus, have been used to establish critical roles for CD8 T cells in the control of primary infection. To study the requirements for protection against secondary infection, we have used a prime-challenge regime, in which avirulent ectromelia virus was used to prime mice that were then challenged with virulent ectromelia virus. In contrast to primary infection, T cells are not required for recovery from secondary infection, since gene knockout mice deficient in CD8 T-cell function and wild-type mice acutely depleted of CD4, CD8, or both subsets were fully protected. Protection correlated with effective virus control and generation of neutralizing antibody. Notably, primed mice that lacked B cells, major histocompatibility complex class II, or CD40 succumbed to secondary infection. Thus, antibody is essential, but CD4 or CD8 T cells are not required for recovery from secondary poxvirus infection.


Subject(s)
Antibodies, Viral/immunology , Antibody Formation/immunology , B-Lymphocytes/immunology , Ectromelia virus/immunology , Ectromelia, Infectious/immunology , Animals , CD4-Positive T-Lymphocytes/immunology , CD40 Antigens/genetics , CD40 Antigens/immunology , CD8-Positive T-Lymphocytes/immunology , Disease Models, Animal , Ectromelia, Infectious/genetics , Female , Genes, MHC Class II/genetics , Genes, MHC Class II/immunology , Humans , Lymphocyte Depletion , Mice , Mice, Inbred BALB C , Mice, Knockout , Smallpox/immunology , Vaccines, Attenuated/immunology
8.
J Virol ; 80(13): 6339-44, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16775322

ABSTRACT

To understand the correlates of protective immunity against primary variola virus infection in humans, we have used the well-characterized mousepox model. This is an excellent surrogate small-animal model for smallpox in which the disease is caused by infection with the closely related orthopoxvirus, ectromelia virus. Similarities between the two infections include virus replication and transmission, aspects of pathology, and development of pock lesions. Previous studies using ectromelia virus have established critical roles for cytokines and effector functions of CD8 T cells in the control of acute stages of poxvirus infection. Here, we have used mice deficient in B cells to demonstrate that B-cell function is also obligatory for complete virus clearance and recovery of the host. In the absence of B cells, virus persists and the host succumbs to infection, despite the generation of CD8 T-cell responses. Intriguingly, transfer of naive B cells or ectromelia virus-immune serum to B-cell-deficient mice with established infection allowed these animals to clear virus and fully recover. In contrast, transfer of ectromelia virus-immune CD8 T cells was ineffective. Our data show that mice deficient in CD8 T-cell function die early in infection, whereas those deficient in B cells or antibody production die much later, indicating that B-cell function becomes critical after the effector phase of the CD8 T-cell response to infection subsides. Strikingly, our results show that antibody prevents virus from seeding the skin and forming pock lesions, which are important for virus transmission between hosts.


Subject(s)
Antibody Formation/immunology , B-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Ectromelia virus/immunology , Ectromelia, Infectious/immunology , Ectromelia, Infectious/transmission , Adoptive Transfer , Animals , Antibodies, Viral/immunology , B-Lymphocytes/transplantation , CD8-Positive T-Lymphocytes/transplantation , Disease Models, Animal , Ectromelia, Infectious/pathology , Female , Humans , Immunity, Cellular/immunology , Lymphocyte Depletion , Mice , Mice, Knockout , Skin/immunology , Skin/pathology , Skin/virology , Smallpox/immunology , Smallpox/pathology , Smallpox/transmission , Variola virus/immunology , Virus Replication/immunology
9.
Proc Natl Acad Sci U S A ; 102(36): 12921-6, 2005 Sep 06.
Article in English | MEDLINE | ID: mdl-16123129

ABSTRACT

IFN function is critical for recovery from most primary viral infections, including poxvirus infection. In contrast, very little is known about the requirement for IFN function in mediating recovery from a secondary virus infection. We have used ectromelia virus (ECTV), an orthopoxvirus very closely related to variola virus, to investigate the importance of IFN function in recovery from a secondary infection. Variola virus, the causative agent of smallpox in humans, and ECTV, which causes mousepox in mice, both encode receptor homologs that are thought to interfere with host IFN function. Using a prime-challenge regime, in which avirulent ECTV is used to prime mice deficient in type I/II IFN function or IFN regulatory factor 1 (IRF-1) and then challenging the mice with a virulent strain, we show that IFN function is redundant for virus clearance during a secondary ECTV infection. A neutralizing Ab response is generated in a secondary infection, even in the absence of IFN function, although when present, IFN strongly influences the neutralizing titer and subtype of IgG that is produced. Importantly, the depletion of CD8+ T lymphocytes during a secondary challenge in IFN-deficient mice does not affect their capacity to clear ECTV, indicating that Ab is critical for the control of a secondary infection.


Subject(s)
Interferons/immunology , Interferons/metabolism , Poxviridae Infections/immunology , Poxviridae/immunology , Animals , CD8-Positive T-Lymphocytes/immunology , Female , Interferons/deficiency , Interferons/genetics , Mice , Mice, Knockout , Poxviridae Infections/metabolism , Poxviridae Infections/virology , Survival Rate , Viral Load
10.
Proc Natl Acad Sci U S A ; 101(24): 9057-62, 2004 Jun 15.
Article in English | MEDLINE | ID: mdl-15184649

ABSTRACT

Ectromelia virus (ECTV), a natural mouse pathogen and an orthopoxvirus, has been used to investigate the correlation between polarized type 1 or type 2 immune responses and resistance to disease in poxvirus infections by using well defined resistant and susceptible mouse strains. Our data show that distinct differences exist in the cytokine profiles expressed in resistant and susceptible mice infected with ECTV. Resistant C57BL/6 mice generate a type 1 cytokine response [IFN-gamma, IL-2, and tumor necrosis factor (TNF)], within the first few days of infection, which is associated with strong cytotoxic T lymphocyte response (CTL) and recovery from ECTV infection. Susceptible strains of mice (BALB/c and A/J) on the other hand generate a type 2 cytokine response (IL-4 but little or no IFN-gamma and IL-2), which is associated with a weak or an absent CTL response, resulting in uncontrolled virus replication and death. Although deletion of IL-4 function alone did not change the outcome of infection in susceptible mice, the loss of IFN-gamma function in resistant mice abrogated natural killer (NK) cell and CTL effector functions resulting in fulminant disease and 100% mortality. Therefore, a clear link exists between the early production of specific type 1 cytokines, in particular, IFN-gamma, the nature of the cellular immune response, and disease outcome in this virus model. This finding in the mousepox model raises the possibility that inappropriate cytokine responses may result in increased susceptibility to smallpox in humans.


Subject(s)
Cytokines/immunology , Ectromelia virus/immunology , Ectromelia, Infectious/immunology , Animals , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cell Line , Cytokines/biosynthesis , Ectromelia, Infectious/genetics , Female , Genetic Predisposition to Disease , Immunity, Cellular/immunology , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Interferon-gamma/biosynthesis , Killer Cells, Natural/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Neutralization Tests , Spleen/cytology , Spleen/immunology , T-Lymphocytes, Cytotoxic/immunology , Viral Load
SELECTION OF CITATIONS
SEARCH DETAIL